Gritstone bio, Inc. - Common Stock (GRTS)

Gritstone Bio Inc is a biotechnology company focused on developing personalized cancer immunotherapies that harness the body's immune system to target and eradicate tumors

The company aims to create innovative treatments tailored to individual patients by utilizing unique tumor-specific neoantigens, which are proteins produced by cancer cells. By leveraging advanced genomic and computational technologies, Gritstone Bio works to enhance the efficacy of immunotherapy, providing hope for improved outcomes in cancer care and addressing significant unmet medical needs within the oncology field.